Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:44 AM
Ignite Modification Date:
2025-12-26 @ 2:31 AM
NCT ID:
NCT00094302
Group ID:
EG001
Title:
Spironolactone
Description:
Spironolactone (an aldosterone antagonist) is supplied as 15 mg tablets. Drug is taken orally by subjects. The initial study drug dose is 15 mg/day (one tablet) and may be titrated up to 30 mg/day (two tablets) or 45 mg/day (three tablets). Subjects are on study drug for the duration of the trial.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
835
Serious Number At Risk:
1722
Other Number Affected:
1152
Other Number At Risk:
1722
Study:
NCT00094302
Results Section:
NCT00094302
Adverse Events Module:
NCT00094302